Scientists say a new malaria vaccine being tested in Mozambique was successful in protecting infants less than 1 year old.
The study, published in The Lancet, was intended to show the safety of the vaccine. GlaxoSmithKline researchers also found that the full course of three shots reduced the risk of catching malaria by 65 percent, The New York Times said.
The efficacy data is consistent with the estimate of 45 percent reduction in new infections reported in a 2004 trial in Mozambique among children one to four years old, GlaxoSmithKline said Thursday in a release.
"We're now a step closer to the realization of a vaccine that can protect African infants," said Dr. Pedro Alonso, the University of Barcelona professor who leads clinical trials of the vaccine.
Copyright 2007 by United Press International
Related stories:
Gates: $258 million for malaria research
The Bill and Melinda Gates Foundation has given $258 million in malaria research grants.
The foundation says malaria kills an estimated 2,000 African children each day and takes the lives of more than 1 million people worldwide annually.
Genome sequences of 2 malaria parasites defined
Professor Alan Cowman, Professor Brendan Crabb, Dr Paul Gilson and Dr Toby Sargeant are WEHI members of international research teams that have made significant discoveries about two deadly malaria parasites,
Plasmodium knowlesi and
Plasmodium vivax.
NTDs burden in Latin America and the Caribbean may exceed that of HIV/AIDS, TB and malaria
According to a new analysis published September 24th in the open-access journal
PLoS Neglected Tropical Diseases, "The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control And Elimination,", neglected tropical diseases (NTDs) as a group may have surpassed HIV/AIDS, tuberculosis and malaria as the most prevalent infectious diseases in Latin America and the Caribbean. The analysis found that NTDs are the most common infections of approximately 200 million of the poorest people in the region. They include tens of millions of cases of intestinal worm infections, and almost 10 million cases of Chagas disease, as well as schistosomiasis, trachoma, dengue fever, leishmaniasis, lymphatic filariasis (LF), and onchocerciasis.
New insights could lead to a better pneumococcal vaccine
Discovery of a new, previously unknown mechanism of immunity suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at Children's Hospital Boston and Harvard School of Public Health (HSPH). The findings, published in the open-access journal
PLoS Pathogens on September 19, may aid the development of novel pneumococcal vaccines. (The current vaccine, Prevnar, is expensive and covers only 7 of the 91 known pneumococcal strains.)
Purifying parasites with light
Researchers have developed a clever method to purify parasitic organisms from their host cells, which will allow for more detailed proteomic studies and a deeper insight into the biology of organisms that cause millions of cases of disease each year.
How the malaria parasite hijacks human red blood cells
A new study—done on a scale an order of magnitude greater than anything previously attempted in the field of malaria—has uncovered an arsenal of proteins produced by the malaria parasite that allows it to hijack and remodel human red blood cells, leaving the oxygen-carrying cells stiff and sticky. Those effects on the blood cells play a major role in the development of malaria, a disease responsible for millions of deaths every year, the researchers report in the July 11th issue of the journal
Cell, a Cell Press publication.
Parasite vaccines within reach
Even though parasites are complex creatures, the mammalian immune response to them is surprisingly simple, leading University of California, Berkeley, researchers to predict that creating vaccines for parasitic diseases such as malaria may be more straightforward than initially thought.
Engineers create new technique for malaria diagnosis
Researchers from the Universities of Exeter and Coventry have developed the first new technique for diagnosing malaria able to challenge the rapid diagnostic tests (RDTs) currently used in the field.